Teva's Shares Now Trade Directly on the NYSE — Here's What Else Changed
Teva Pharmaceutical Industries had a busy week that included a major debt refinancing, a NYSE trading shift and analyst activity.
Stocks · News reference
Teva Priced Approximately $4.9B (Equivalent) of Senior Notes
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) ("Teva") announced today that it successfully priced its offering of approximately $4.9 billion (equivalent) of senior notes (the "Notes"). Teva
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Teva Pharmaceutical shares are trading higher. The company announced that its ordinary shares will begin trading directly on the NYSE completing the company’s planned transition from its ADSs program.
Teva Pharmaceutical Announces Ordinary Shares Begin Trading Directly On NYSE Monday, September 14 Under Ticker TEVA